A1120, a Nonretinoid RBP4 Antagonist, Inhibits Formation of Cytotoxic Bisretinoids in the Animal Model of Enhanced Retinal Lipofuscinogenesis

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086 · see citing works

A transcriptional co-repressor that interacts with nuclear hormone receptors

Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,794 · see citing works

RPE lipofuscin and its role in retinal pathobiology

Sparrow, J. R., & Boulton, M. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.01.007 · Cited by 644 · see citing works

Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells.

Feeney-Burns, L., Hilderbrand, E. S., & Eldridge, S. (1984) · PubMed · Cited by 561 · see citing works

Impaired retinal function and vitamin A availability in mice lacking retinol‐binding protein

Quadro, L., Blaner, W. S., Salchow, D. J., Vogel, S., Piantedosi, R., Gouras, P., Freeman, S., Cosma, M. P., Colantuoni, V., & Gottesman, M. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4633 · Cited by 506 · see citing works

Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration.

Dorey, C. K., Wu, G., Ebenstein, D., Garsd, A., & Weiter, J. J. (1989) · PubMed · Cited by 488 · see citing works

Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.

Holz, F. G., Bellman, C., STAUDT, S., Schütt, F., & Völcher, H. E. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01394-0 · Cited by 426 · see citing works

The bisretinoids of retinal pigment epithelium

Sparrow, J. R., Gregory-Roberts, E., Yamamoto, K., Blonska, A., Ghosh, S. K., Ueda, K., & Zhou, J. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.12.001 · Cited by 392 · see citing works

Binding Affinities of Retinol and Related Compounds to Retinol Binding Proteins

Cogan, U., Kopelman, M., Mokady, S., & Shinitzky, M. (1976) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1976.tb10390.x · Cited by 381 · see citing works

A2E, a byproduct of the visual cycle

Sparrow, J. R., Fishkin, N., Zhou, J., Cai, B., Jang, Y. P., Krane, S., Itagaki, Y., & Nakanishi, K. (2003) · Vision Research · doi:10.1016/s0042-6989(03)00475-9 · Cited by 318 · see citing works

Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope

Struharova, K., & Černák, M. (2012) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2012_026 · Cited by 274 · see citing works

The coactivator LXXLL nuclear receptor recognition motif

Savkur, R. S., & Burris, T. P. (2004) · Journal of Peptide Research · doi:10.1111/j.1399-3011.2004.00126.x · Cited by 263 · see citing works

Fundus autofluorescence and age-related macular degeneration

Spaide, R. F. (2003) · Ophthalmology · doi:10.1016/s0161-6420(02)01756-6 · Cited by 257 · see citing works

Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.

Holz, F. G., Bellman, C., STAUDT, S., Schütt, F., & Völcker, H. E. (2001) · PubMed · Cited by 242 · see citing works

Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration

Radu, R. A., Mata, N. L., Nusinowitz, S., Liu, X., Sieving, P. A., & Travis, G. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737855100 · Cited by 227 · see citing works

Reductions in Serum Vitamin A Arrest Accumulation of Toxic Retinal Fluorophores: A Potential Therapy for Treatment of Lipofuscin-Based Retinal Diseases

Radu, R. A., Han, Y., Bui, T. V., Nusinowitz, S., Bok, D., Lichter, J. B., Widder, K., Travis, G. H., & Mata, N. L. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0820 · Cited by 225 · see citing works

Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope.

von Rückmann, A., Fitzke, F. W., & Bird, A. C. (1997) · PubMed · Cited by 206 · see citing works

Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E

Kim, S. R., Fishkin, N. E., Kong, J., Nakanishi, K., Allikmets, R. L., & Sparrow, J. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403499101 · Cited by 146 · see citing works

CELL LOSS IN THE AGING RETINA

Dorey, C. K., Wu, G., Ebenstein, D., Garsd, A., & Weiter, J. J. (1989) · Cited by 141 · see citing works

Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors

Lee*, J. W., Lee, Y. C., Na, S.-Y., Jung, D.-J., & Lee, S.-K. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000856 · Cited by 139 · see citing works

Lipofuscin and N-Retinylidene-N-Retinylethanolamine (A2E) Accumulate in Retinal Pigment Epithelium in Absence of Light Exposure

Boyer, N. P., Higbee, D., Currin, M. B., Blakeley, L. R., Chen, C., Ablonczy, Z., Crouch, R. K., & Koutalos, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.329235 · Cited by 133 · see citing works

Interactions of retinol with binding proteins: implications for the mechanism of uptake by cells

Noy, N., & Xu, Z. (1990) · Biochemistry · doi:10.1021/bi00468a012 · Cited by 127 · see citing works

Classical and novel retinoids: their targets in cancer therapy

Fontana, J. A., & Rishi, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402414 · Cited by 125 · see citing works

Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle

Golczak, M., Kuksa, V., Maeda, T., Moise, A. R., & Palczewski, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503318102 · Cited by 124 · see citing works

Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.

Clifford, J. L., Menter, D. G., Wang, M., Lotan, R., & Lippman, S. M. (1999) · PubMed · Cited by 119 · see citing works

Retinyl Esters Are the Substrate for Isomerohydrolase

Moiseyev, G., Crouch, R. K., Goletz, P., Oatis, Redmond, T. M., & Ma, J.-X. (2003) · Biochemistry · doi:10.1021/bi026911y · Cited by 116 · see citing works

Retinoids for treatment of retinal diseases

Palczewski, K. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.03.001 · Cited by 111 · see citing works

Small Molecule RPE65 Antagonists Limit the Visual Cycle and Prevent Lipofuscin Formation

Maiti, P., Kong, J., Kim, S. R., Sparrow, J. R., Allikmets, R. L., & Rando, R. R. (2005) · Biochemistry · doi:10.1021/bi0518545 · Cited by 106 · see citing works

In vitro interaction of fenretinide with plasma retinol‐binding protein and its functional consequences

Berni, R., & Formelli, F. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81046-o · Cited by 105 · see citing works

SAFETY AND EFFECT ON ROD FUNCTION OF ACU-4429, A NOVEL SMALL-MOLECULE VISUAL CYCLE MODULATOR

Kubota, R., Boman, N. L., David, R., Mallikaarjun, S., Patil, S., & Birch, D. G. (2011) · Retina · doi:10.1097/iae.0b013e318217369e · Cited by 98 · see citing works

Hemangiosarcoma in Rodents: Mode-of-Action Evaluation and Human Relevance

Cohen, S. M., Storer, R. D., Criswell, K. A., Doerrer, N. G., Dellarco, V. L., Pegg, D. G., Wojcinski, Z. W., Malarkey, D. E., Jacobs, A. C., Klaunig, J. E., et al. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp131 · Cited by 97 · see citing works

[19] High-performance liquid chromatography analysis of visual cycle retinoids

Garwin, G. G., & Saari, J. C. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)16731-x · Cited by 96 · see citing works

Lecithin:Retinol Acyltransferase Is Critical for Cellular Uptake of Vitamin A from Serum Retinol-binding Protein

Amengual, J., Golczak, M., Palczewski, K., & von Lintig, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353979 · Cited by 93 · see citing works

Retinol binding protein as a surrogate measure for serum retinol: studies in vitamin A–deficient children from the Republic of the Marshall Islands

Gamble, M. V., Ramakrishnan, R., Palafox, N. A., Briand, K., Berglund, L., & Blaner, W. S. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.3.594 · Cited by 86 · see citing works

Identification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in Vivo

Motani, A. S., Wang, Z., Conn, M. T., Siegler, K., Zhang, Y., Liu, Q., Johnstone, S., Xu, H., Thibault, S., Wang, Y., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809654200 · Cited by 83 · see citing works

Effects of Potent Inhibitors of the Retinoid Cycle on Visual Function and Photoreceptor Protection from Light Damage in Mice

Maeda, A., Maeda, T., Golczak, M., Imanishi, Y., Leahy, P. S., Kubota, R., & Palczewski, K. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026823 · Cited by 79 · see citing works

β-Carotene Conversion into Vitamin A in Human Retinal Pigment Epithelial Cells

Chichili, G. R., Nöhr, D., ̈ffer, M. S., Lintig, J. V., & Biesalski, H. K. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0089 · Cited by 72 · see citing works

α-Phenyl-N-tert-butylnitrone (PBN) Prevents Light-induced Degeneration of the Retina by Inhibiting RPE65 Protein Isomerohydrolase Activity

Mandal, M. N. A., Moiseyev, G. P., Elliott, M. H., Kasus-Jacobi, A., Li, X., Chen, H., Zheng, L., Nikolaeva, O., Floyd, R. A., Ma, J.-X., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.255877 · Cited by 56 · see citing works

New therapeutic targets in atrophic age-related macular degeneration

Petrukhin, K. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.625 · Cited by 53 · see citing works

A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.

Simeone, A., Ekmekçioglu, S., Broemeling, L. D., Grimm, E. A., & Tari, A. M. (2002) · PubMed · Cited by 46 · see citing works

Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines

Holmes, W. F., Soprano, D. R., & Soprano, K. J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10338 · Cited by 43 · see citing works

N‐(4‐hydroxyphenyl)retinamide induces apoptosis in human retinal pigment epithelial cells: Retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase‐1 and Gadd153

Samuel, W., Kutty, R. K., Nagineni, S., Vijayasarathy, C., Chandraratna, R. A. S., & Wiggert, B. O. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20774 · Cited by 40 · see citing works

Fenretinide activates caspases and induces apoptosis in gliomas.

Puduvalli, V. K., Saito, Y., Xu, R., Kouraklis, G. P., Levin, V. A., & Kyritsis, A. P. (1999) · PubMed · Cited by 39 · see citing works

Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.

Sabichi, A. L., Xu, H., Fischer, S. M., Zou, C., Yang, X., Steele, V. E., Kelloff, G. J., Lotan, R., & Clifford, J. L. (2003) · PubMed · Cited by 36 · see citing works

Comparative teratogenicity of nine retinoids in the rat.

Turton, J. A., Willars, G. B., Haselden, J. N., Ward, S. J., Steele, C. E., & Hicks, R. M. (1992) · Europe PMC (PubMed Central) · Cited by 32 · see citing works

N-(4-Hydroxyphenyl)retinamide (Fenretinide) Induces Retinol-Binding Protein Secretion from Liver and Accumulation in the Kidneys in Rats

Schaffer, E. M., Ritter, S. J., & Smith, J. E. (1993) · Journal of Nutrition · doi:10.1093/jn/123.9.1497 · Cited by 27 · see citing works

Fenretinide and risk reduction of second breast cancer

DeCensi, A., Zanardi, S., Argusti, A., Bonanni, B., Costa, A., & Veronesi, U. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0735 · Cited by 21 · see citing works

RPE lipofuscin in ageing and age-related macular degeneration

Delori, F. C. (1998) · Documenta ophthalmologica. Proceedings series · doi:10.1007/978-94-011-5137-5_7 · Cited by 20 · see citing works

Effects of N-(4-Hydroxyphenyl)retinamide on Vitamin A Metabolism in Rats

Adams, W. R., Smith, J. E., & Green, M. H. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-208-43849 · Cited by 17 · see citing works

Small Molecule RPE65 Antagonists Limit the Visual Cycle and Prevent Lipofuscin Formation,

Maiti, P., Kong, J., Kim, S. R., Sparrow, J. R., Allikmets, R. L., & Rando, R. R. (2007) · Biochemistry · doi:10.1021/bi701061k · Cited by 13 · see citing works

Sensitivity to DNA Damage Is a Common Component of Hormone-Based Strategies for Protection of the Mammary Gland

Tu, Y., Jerry, D. J., Pazik, B., & Schneider, S. S. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0038 · Cited by 12 · see citing works

Assay of Retinol-Binding Protein–Transthyretin Interaction and Techniques to Identify Competing Ligands

Mata, N. L., Phan, K. B., & Han, Y. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-325-1_12 · Cited by 4 · see citing works

Biological Functions of RBP4 and Its Relevance for Human Diseases

Steinhoff, J. S., Lass, A., & Schupp, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.659977 · Cited by 182 · see citing works

Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration

Ueda, K., Zhao, J., Kim, H. J., & Sparrow, J. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524774113 · Cited by 115 · see citing works

The Role of Vitamin A in Retinal Diseases

Sajovic, J., Meglič, A., Glavač, D., Markelj, Š., Hawlina, M., & Fakin, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031014 · Cited by 109 · see citing works

Retinoids and Retinal Diseases

Kiser, P. D., & Palczewski, K. (2016) · Annual Review of Vision Science · doi:10.1146/annurev-vision-111815-114407 · Cited by 108 · see citing works

Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function

Salzer, B., Schueller, C. M., Zajc, C. U., Peters, T., Schoeber, M. A., Kovačic, B., Buri, M. C., Lobner, E., Dushek, O., Huppa, J. B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17970-3 · Cited by 102 · see citing works

A conformation-specific ON-switch for controlling CAR T cells with an orally available drug

Zajc, C. U., Dobersberger, M., Schaffner, I., Mlynek, G., Pühringer, D., Salzer, B., Djinović‐Carugo, K., Steinberger, P., Linhares, A. D. S., Yang, N. J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911154117 · Cited by 98 · see citing works

Retinol-binding protein 4 in obesity and metabolic dysfunctions

Nankam, P. A. N., & Blüher, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111312 · Cited by 91 · see citing works

Recent Advances in Age-Related Macular Degeneration Therapies

Fabre, M., Mateo, L., Lamaa, D., Baillif, S., Pagès, G., Demange, L., Ronco, C., & Benhida, R. (2022) · Molecules · doi:10.3390/molecules27165089 · Cited by 95 · see citing works

Retinoid Homeostasis and Beyond: How Retinol Binding Protein 4 Contributes to Health and Disease

Steinhoff, J. S., Lass, A., & Schupp, M. (2022) · Nutrients · doi:10.3390/nu14061236 · Cited by 73 · see citing works

Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review

Waugh, N. R., Loveman, E., Colquitt, J. L., Royle, P., Yeong, J. L., Hoad, G. V., & Lois, N. (2018) · Health Technology Assessment · doi:10.3310/hta22270 · Cited by 70 · see citing works

An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story

Al‐Khuzaei, S., Broadgate, S., Foster, C. R., Shah, M., Yu, J., Downes, S. M., & Halford, S. (2021) · Genes · doi:10.3390/genes12081241 · Cited by 73 · see citing works

Novel therapeutics for Stargardt disease

Lu, L. J., Liu, J., & Adelman, R. A. (2017) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-017-3619-8 · Cited by 69 · see citing works

Lipofuscin, Its Origin, Properties, and Contribution to Retinal Fluorescence as a Potential Biomarker of Oxidative Damage to the Retina

Rôżanowska, M. (2023) · Antioxidants · doi:10.3390/antiox12122111 · Cited by 59 · see citing works

Update on current and future novel therapies for dry age-related macular degeneration

Leung, E. H., & Landa, G. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.829645 · Cited by 59 · see citing works

Inner and Outer Retinal Changes in Retinal Degenerations Associated With ABCA4 Mutations

Huang, W. C., Cideciyan, A. V., Román, A. J., Sumaroka, A., Sheplock, R., Schwartz, S., Stone, E. M., & Jacobson, S. G. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13768 · Cited by 58 · see citing works

Stargardt macular dystrophy and evolving therapies

Hussain, R. M., Ciulla, T. A., Berrocal, A. M., Gregori, N. Z., Flynn, H. W., & Lam, B. L. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1513486 · Cited by 56 · see citing works

Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease

Cioffi, C. L., Dobri, N., Freeman, E. E., Conlon, M. P., Chen, P., Stafford, D. G., Schwarz, D. M. C., Golden, K. C., Zhu, L., Kitchen, D. B., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010013 · Cited by 56 · see citing works

Stargardt disease and progress in therapeutic strategies

Huang, D., Jeffery, R. C. H., Aung-Htut, M. T., McLenachan, S., Fletcher, S., Wilton, S. D., & Chen, F. K. (2021) · Ophthalmic Genetics · doi:10.1080/13816810.2021.1966053 · Cited by 56 · see citing works

Pharmacotherapy of retinal disease with visual cycle modulators

Hussain, R. M., Gregori, N. Z., Ciulla, T. A., & Lam, B. L. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1448060 · Cited by 51 · see citing works

Therapy Approaches for Stargardt Disease

Piotter, E., McClements, M. E., & MacLaren, R. E. (2021) · Biomolecules · doi:10.3390/biom11081179 · Cited by 49 · see citing works

Predicting Progression of ABCA4 -Associated Retinal Degenerations Based on Longitudinal Measurements of the Leading Disease Front

Cideciyan, A. V., Świder, M., Schwartz, S., Stone, E. M., & Jacobson, S. G. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17698 · Cited by 47 · see citing works

Effects of deficiency in the RLBP1-encoded visual cycle protein CRALBP on visual dysfunction in humans and mice

Lima de Carvalho, J. R., Kim, H. J., Ueda, K., Zhao, J., Owji, A. P., Yang, T., Tsang, S. H., & Sparrow, J. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012695 · Cited by 42 · see citing works

Deep learning segmentation of hyperautofluorescent fleck lesions in Stargardt disease

Charng, J., Xiao, D., Mehdizadeh, M., Attia, M. S., Arunachalam, S., Lamey, T. M., Thompson, J. A., McLaren, T. L., Roach, J. N. D., Mackey, D. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73339-y · Cited by 43 · see citing works

RNA‐seq analysis of ageing human retinal pigment epithelium: Unexpected up‐regulation of visual cycle gene transcription

Butler, J. M., Supharattanasitthi, W., Yang, Y. C., & Paraoan, L. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16569 · Cited by 42 · see citing works

Genetic Background and Light-Dependent Progression of Photoreceptor Cell Degeneration in Prominin-1 Knockout Mice

Dellett, M., Sasai, N., Nishide, K., Becker, S., Papadaki, V., Limb, G. A., Moore, A. T., Kondo, T., & Ohnuma, S. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15479 · Cited by 41 · see citing works

A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle

Rácz, B., Váradi, A., Kong, J., Allikmets, R. L., Pearson, P. G., Johnson, G., Cioffi, C. L., & Petrukhin, K. E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002062 · Cited by 40 · see citing works

Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics

Sparrow, J. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600474113 · Cited by 39 · see citing works

Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development

Kim, N., & Priefer, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113856 · Cited by 38 · see citing works

Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment

Petrukhin, K. E. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.05.004 · Cited by 37 · see citing works

Complement pathway biomarkers and age-related macular degeneration

Gemenetzi, M. K., & Lotery, A. J. (2015) · Eye · doi:10.1038/eye.2015.203 · Cited by 38 · see citing works

Bicyclic [3.3.0]-Octahydrocyclopenta[ c ]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease

Cioffi, C. L., Rácz, B., Freeman, E. E., Conlon, M. P., Chen, P., Stafford, D. G., Schwarz, D. M. C., Zhu, L., Kitchen, D. B., Barnes, K. D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00423 · Cited by 35 · see citing works

Investigational drugs in clinical trials for macular degeneration

Tolentino, M. J., & Tolentino, A. J. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2113375 · Cited by 34 · see citing works

Abnormal Cannabidiol Modulates Vitamin A Metabolism by Acting as a Competitive Inhibitor of CRBP1

Silvaroli, J. A., Widjaja‐Adhi, M. A. K., Trischman, T., Chełstowska, S., Horwitz, S. M., Banerjee, S., Kiser, P. D., Blaner, W. S., & Golczak, M. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b01070 · Cited by 32 · see citing works

Novel bisretinoids of human retina are lyso alkyl ether glycerophosphoethanolamine-bearing A2PE species

Kim, H. J., & Sparrow, J. R. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m084459 · Cited by 31 · see citing works

Potential Therapeutic Agents Against Retinal Diseases Caused by Aberrant Metabolism of Retinoids

Liu, X., Chen, J., Liu, Z., Li, J., Yao, K., & Wu, Y. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18429 · Cited by 29 · see citing works

Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis

Cioffi, C. L., Rácz, B., Váradi, A., Freeman, E. E., Conlon, M. P., Chen, P., Zhu, L., Kitchen, D. B., Barnes, K. D., Martin, W. H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00352 · Cited by 29 · see citing works

ABCA4-Associated Stargardt Disease

Khan, M., & Cremers, F. P. M. (2020) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-1057-9939 · Cited by 27 · see citing works

RBP4 promotes denervation‐induced muscle atrophy through STRA6‐dependent pathway

Zhang, K., Li, J., Xu, J., Shen, Z., Lin, Y., Zhao, C., Lü, X., Rui, Y., & Gao, W. Q. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13518 · Cited by 25 · see citing works

Penetration, distribution, and elimination of remofuscin/soraprazan in Stargardt mouse eyes following a single intravitreal injection using pharmacokinetics and transmission electron microscopic autoradiography: Implication for the local treatment of Stargardt’s disease and dry age‐related macular degeneration

Julien, S., Illing, B., Tschulakow, A., Taubitz, T., Guezguez, J., Burnet, M. W. M., & Schraermeyer, U. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.683 · Cited by 25 · see citing works

Non-photopic and photopic visual cycles differentially regulate immediate, early, and late phases of cone photoreceptor-mediated vision

Ward, R. H. R., Kaylor, J. J., Cobice, D., Pepe, D. A., McGarrigle, E. M., Brockerhoff, S. E., Hurley, J. B., Travis, G. H., & Kennedy, B. N. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011374 · Cited by 25 · see citing works

Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo

Fontaine, V. K., Monteiro, E., Brazhnikova, E., Lesage, L., Balducci, C., Guibout, L., Feraille, L., Elena, P.-P., Sahel, J., Veillet, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167793 · Cited by 23 · see citing works

Dry Age-Related Macular Degeneration Pharmacology

Wright, C. B., & Ambati, J. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_36 · Cited by 22 · see citing works

Monitoring and Management of the Patient with Stargardt Disease

Cicinelli, M. V., Battista, M., Starace, V., Parodi, M. B., & Bandello, F. M. (2019) · Clinical Optometry · doi:10.2147/opto.s226595 · Cited by 21 · see citing works

Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies

Banerjee, A., & Singh, J. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10150 · Cited by 20 · see citing works

Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities

Cioffi, C. L., Muthuraman, P., Raja, A., Váradi, A., Rácz, B., & Petrukhin, K. E. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00996 · Cited by 20 · see citing works

Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1

Poliakov, E., Samuel, W., Duncan, T. E., Gutierrez, D. B., Mata, N. L., & Redmond, T. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176487 · Cited by 19 · see citing works

Retinal degeneration in animal models with a defective visual cycle

Maeda, A., & Palczewski, K. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2014.01.001 · Cited by 18 · see citing works

Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4

Wang, Y., Connors, R., Fan, P., Wang, X., Wang, Z., Liu, J., Kayser, F., Medina, J. C., Johnstone, S., Xu, H., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.089 · Cited by 17 · see citing works

Updates on Emerging Interventions for Autosomal Recessive ABCA4-Associated Stargardt Disease

Wang, L., Shah, S. M., Mangwani‐Mordani, S., & Gregori, N. Z. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196229 · Cited by 19 · see citing works

Smart Nanocarriers for the Treatment of Retinal Diseases

Liu, S., Yan, Z., Huang, Z., Yang, H., & Li, J. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c01289 · Cited by 16 · see citing works

Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration

Yeong, J. L., Loveman, E., Colquitt, J. L., Royle, P., Waugh, N. R., & Lois, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013154.pub2 · Cited by 16 · see citing works

Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration

Du, M., Phelps, E., Balangue, M. J., Dockins, A., Moiseyev, G. P., Shin, Y., Kane, S., Otalora, L., Ma, J., Farjo, R. A., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22107 · Cited by 16 · see citing works

Advances and therapeutic opportunities in visual cycle modulation

Zaluski, J., Bassetto, M., Kiser, P. D., & Tochtrop, G. P. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101360 · Cited by 15 · see citing works

Products of the visual cycle are detected in mice lacking retinol binding protein 4, the only known vitamin A carrier in plasma

Montenegro, D., Zhao, J., Kim, H. J., Shmarakov, I. O., Blaner, W. S., & Sparrow, J. R. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102722 · Cited by 14 · see citing works

Recent advancements and applications of ophthalmic gene therapy strategies: A breakthrough in ocular therapeutics

Maurya, R., Vikal, A., Narang, R. K., Patel, P., & Kurmi, B. D. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109983 · Cited by 13 · see citing works

Identification of Transthyretin Tetramer Kinetic Stabilizers That Are Capable of Inhibiting the Retinol-Dependent Retinol Binding Protein 4-Transthyretin Interaction: Potential Novel Therapeutics for Macular Degeneration, Transthyretin Amyloidosis, and Their Common Age-Related Comorbidities

Cioffi, C. L., Raja, A., Muthuraman, P., Jayaraman, A., Jayakumar, S., Váradi, A., Rácz, B., & Petrukhin, K. E. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00099 · Cited by 13 · see citing works

Adipocyte HSL is required for maintaining circulating vitamin A and RBP4 levels during fasting

Steinhoff, J. S., Wagner, C., Dähnhardt, H. E., Košić, K., Meng, Y., Taschler, U., Pajed, L., Yang, N. Y., Wulff, S., Kiefer, M. F., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00158-x · Cited by 13 · see citing works

Targeting Retinol-Binding Protein 4 (RBP4) in the Management of Cardiometabolic Diseases

Oluwamodupe, C., & Adeleye, A. O. (2023) · Cardiovascular Toxicology · doi:10.1007/s12012-023-09803-8 · Cited by 12 · see citing works

A high fat diet fosters elevated bisretinoids

Kim, H. J., Zhao, J., Walewski, J. L., & Sparrow, J. R. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104784 · Cited by 11 · see citing works

Multifunctional PEG Retinylamine Conjugate Provides Prolonged Protection against Retinal Degeneration in Mice

Yu, G.-P., Wu, X., Ayat, N. R., Maeda, A., Gao, S.-Q., Golczak, M., Palczewski, K., & Lu, Z. (2014) · Biomacromolecules · doi:10.1021/bm501352s · Cited by 11 · see citing works

Aptamer-Conjugated Calcium Phosphate Nanoparticles for Reducing Diabetes Risk via Retinol Binding Protein 4 Inhibition

Torabi, R., Ghourchian, H., Amanlou, M., & Pasalar, P. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.11.001 · Cited by 11 · see citing works

Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey

Rácz, B., Váradi, A., Pearson, P. G., & Petrukhin, K. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228291 · Cited by 9 · see citing works

Discovery of Nonretinoid Inhibitors of CRBP1: Structural and Dynamic Insights for Ligand-Binding Mechanisms

Plau, J., Morgan, C. E., Federov, Y., Banerjee, S., Adams, D., Blaner, W. S., Yu, E. W., & Golczak, M. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00402 · Cited by 8 · see citing works

Retinoid dynamics in vision: from visual cycle biology to retina disease treatments

Swigris, J., Widjaja‐Adhi, M. A. K., & Golczak, M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108902 · Cited by 8 · see citing works

Drug Discovery Strategies for Inherited Retinal Degenerations

Das, A., & Imanishi, Y. (2022) · Biology · doi:10.3390/biology11091338 · Cited by 7 · see citing works

Peptide Derivatives of Retinylamine Prevent Retinal Degeneration with Minimal Side Effects on Vision in Mice

Yu, G.-P., Gao, S., Dong, Z., Li, S., Sun, D., Zhang, N., Zhang, J., Margeivicus, S., Fu, P., Golczak, M., et al. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00043 · Cited by 7 · see citing works

The role of multimodal imaging and vision function testing in ABCA4 -related retinopathies and their relevance to future therapeutic interventions

Al‐Khuzaei, S., Shah, M., Foster, C. R., Yu, J., Broadgate, S., Halford, S., & Downes, S. M. (2021) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414211056384 · Cited by 7 · see citing works

Vitamin A aldehyde-taurine adducts function in photoreceptor cells

Kim, H. J., Zhao, J., & Sparrow, J. R. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102386 · Cited by 7 · see citing works

Excessive retinol intake exacerbates choroidal neovascularization through upregulated vascular endothelial growth factor in retinal pigment epithelium in mice

Tan, X., Takahashi, H., Nishida, J., Aoki, A., Inoue, T., & Yanagi, Y. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.01.005 · Cited by 7 · see citing works

Recent Developments in Agents for the Treatment of Age-Related Macular Degeneration and Stargardt Disease

Petrukhin, K. E. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_105 · Cited by 6 · see citing works

Electroretinography as a Biomarker to Monitor the Progression of Stargardt Disease

Sajovic, J., Meglič, A., Hawlina, M., & Fakin, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416161 · Cited by 5 · see citing works

Current and emerging therapies for dry and neovascular age-related macular degeneration

Abdulrazzaq, G., Merkhan, M. M., Billa, N., Alany, R. G., Amoaku, W. M. K., Tint, N. L., Ahmad, Z., & Qutachi, O. (2025) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2025.2562196 · Cited by 6 · see citing works

Discovery of phenylpyrrolidine derivatives as a novel class of retinol binding protein 4 (RBP4) reducers

Nakamura, S., Kamaura, M., Akao, Y., Nakamura, N., Mizukami, A., Goto, A., Furuyama, N., Cho, N., & Kasai, S. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116553 · Cited by 5 · see citing works

Recent Advances on Small-Molecule Inhibitors of Lipocalin-like Proteins

Chen, S., Pan, Z., Liu, M., Guo, L., Jiang, X. L., & He, G. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00086 · Cited by 4 · see citing works

Recent Progress in Small-Molecule Agents Against Age-Related Macular Degeneration

Mogi, M., Adams, C. M., Ji, N., & Mainolfi, N. (2013) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-417150-3.00022-3 · Cited by 3 · see citing works

The Potential Role of Retinol-Binding Protein 4 in Heart Failure: A Review

Liu, J., & Wang, Y. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm40127 · Cited by 2 · see citing works

Retinol-binding protein 4 in cardiovascular diseases: mechanisms and therapeutic perspectives

Chen, J., Chen, G., Xu, X., Zhang, J., & Liu, F. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1703840 · Cited by 3 · see citing works

New possibilities in the treatment of Stargardt disease

Zhorzholadze, N. V., Sheremet, N. L., Tanas, A. S., & Strelnikov, V. V. (2020) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2020136042333 · Cited by 2 · see citing works

Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration

Yeong, J. L., Loveman, E., Colquitt, J. L., Royle, P., Waugh, N. R., & Lois, N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013154 · Cited by 2 · see citing works

Inactivation of cellular retinol-binding protein 1 protects against bis-retinoid accumulation and light-induced retinal degeneration in mice

Widjaja‐Adhi, M. A. K., Swigris, J., Plau, J., Chung, C., Walczak, A., Jastrzębska, B., Blaner, W. S., & Golczak, M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110538 · Cited by 1 · see citing works

Stargardt disease: progress, enigmas, and prospects for therapeutic intervention

Palmgren, V. A. C., Pindwarawala, M., Hosseinzadeh, A., & Molday, R. S. (2026) · Expert Review of Ophthalmology · doi:10.1080/17469899.2026.2645188 · Cited by 1 · see citing works

Trial Interventions in ABCA4- RetinopathyPreprint

Breiki, M. A. (2020) · doi:10.14293/s2199-1006.1.sor-.ppz0nmp.v1 · Cited by 1 · see citing works

Engineering human protein switches for functional control of CARs and transcription factors via oral drug administrationPreprint

Sylvander, E., Muñoz‐López, Á., D’Accardio, G., Emminger, D., Mouratidis, K., Engert, F., Baik, H., Balaji, S., Michls, T., Buri, M. C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.17.683068 · Cited by 1 · see citing works

Treatment of Geographic Atrophy: What’s on the Horizon?

Thorell, M. R., & Rosenfeld, P. J. (2014) · Current Ophthalmology Reports · doi:10.1007/s40135-013-0036-y

Oxidative damage in the retina

Stratton, R. D. (2016) · Wiley eBooks · doi:10.1002/9781118832431.ch7

Inherited Retinal Diseases

Moshiri, A., & Yazdanyar, A. (2018) · Current practices in ophthalmology · doi:10.1007/978-981-10-8545-1_5

Stargardt Disease (ABCA4-Associated Retinopathies)

Utz, V. M., & Traboulsi, E. I. (2025) · doi:10.1093/med/9780197659403.003.0037

Targeting Angiogenesis and Visual Cycle in Age-Related Macular Degeneration: The Role of Stem Cells and Vinpocetine

Almpanidou, S., Gounari, E., Goulas, A., Topouzis, F., Talimtzi, P., Kouzi‐Koliakou, K., Karampatakis, V. E., & Koliakos, G. (2025) · Cureus · doi:10.7759/cureus.93878

Intracellular Retinoid-Binding Proteins (CRBP, CRALBP, CRABP) as Emerging Drug Targets in Retinal Disease

Bagale, L. R., & Kim, H. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167096

Structural and biochemical basis for retinol‐binding protein 4 antagonism by tinlarebant

Bassetto, M., & Kiser, P. D. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70687

BindingDB Entry 50021299: Recent Advances on Small-Molecule Inhibitors of Lipocalin-like Proteins.

BindingDB (2025) · UC San Diego · doi:10.7270/q2x3533h

BindingDB Entry 50004352: Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis.

BindingDB (2021) · UC San Diego · doi:10.7270/q290272z

BindingDB Entry 50044691: Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease.

BindingDB (2016) · UC San Diego · doi:10.7270/q2fb54jt

BindingDB Entry 50012048: Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.

BindingDB (2022) · UC San Diego · doi:10.7270/q2251ntz

BindingDB Entry 50044493: Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4.

BindingDB (2015) · UC San Diego · doi:10.7270/q2154jmv

BindingDB Entry 50046294: Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease.

BindingDB (2016) · UC San Diego · doi:10.7270/q20z751f

BindingDB Entry 50014876: Identification of Transthyretin Tetramer Kinetic Stabilizers That Are Capable of Inhibiting the Retinol-Dependent Retinol Binding Protein 4-Transthyretin Interaction: Potential Novel Therapeutics for Macular Degeneration, Transthyretin Amyloidosis, and Their Common Age-Related Comorbidities.

BindingDB (2023) · UC San Diego · doi:10.7270/q2dr30c0

Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease

Cioffi, C. L., Dobri, N., Freeman, E. E., Conlon, M. P., Chen, P., Stafford, D. G., Schwarz, D. M. C., Golden, K. C., Zhu, L., Kitchen, D. B., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010013 · Cited by 56 · see citing works

Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic

(2016)

A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle

Rácz, B., Váradi, A., Kong, J., Allikmets, R. L., Pearson, P. G., Johnson, G., Cioffi, C. L., & Petrukhin, K. E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002062 · Cited by 40 · see citing works

Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities

Cioffi, C. L., Muthuraman, P., Raja, A., Váradi, A., Rácz, B., & Petrukhin, K. E. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00996 · Cited by 20 · see citing works

Bicyclic [3.3.0]-Octahydrocyclopenta[ c ]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease

Cioffi, C. L., Rácz, B., Freeman, E. E., Conlon, M. P., Chen, P., Stafford, D. G., Schwarz, D. M. C., Zhu, L., Kitchen, D. B., Barnes, K. D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00423 · Cited by 35 · see citing works